XML 23 R13.htm IDEA: XBRL DOCUMENT v3.26.1

OTHER ACCRUED EXPENSES

3 Months Ended

Mar. 31, 2026

Payables and Accruals [Abstract]

OTHER ACCRUED EXPENSES

3. OTHER ACCRUED EXPENSES

Other accrued expenses as of March 31, 2026 and December 31, 2025 consisted of the following:

Schedule of other accrued expenses
		March 31, 2026				December 31, 2025
Accrued clinical study costs		$	2,365,362			$	3,169,433
Other accrued expenses			237,249				397,971
Total other accrued expenses		$	2,602,611			$	3,567,404

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 720
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483384/720-30-45-1

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration